Cargando…

Perspective on model‐informed drug development

Model‐informed drug development (MIDD) is a process intended to expedite drug development, enhance regulatory science, and produce benefits for patients. Quantitative modeling and simulation—principally by population pharmacokinetics (PK), exposure–response, and physiologically based pharmacokinetic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lesko, Lawrence J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520742/ https://www.ncbi.nlm.nih.gov/pubmed/34404115 http://dx.doi.org/10.1002/psp4.12699

Ejemplares similares

Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
por: Keizer, Ron J., et al.
Publicado: (2018)

Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program
por: Galluppi, Gerald R., et al.
Publicado: (2021)

Model Informed Drug Development: Collaboration Through A Common Framework
por: Anziano, Richard J., et al.
Publicado: (2020)

Model Informed Drug Development and Regulation in China: Challenges and Opportunities
por: Li, Li, et al.
Publicado: (2019)

A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
por: Madabushi, Rajanikanth, et al.
Publicado: (2019)

PDUFA VI: It Is Time to Unleash the Full Potential of Model‐Informed Drug Development
por: Jain, Lokesh, et al.
Publicado: (2018)

Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
por: Franssen, Linnea C., et al.
Publicado: (2022)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Establishing a Multidisciplinary Framework to Study Drug‐Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate
por: Lesko, Lawrence J., et al.
Publicado: (2018)

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective
por: Manolis, Efthymios, et al.
Publicado: (2023)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development
por: Fermini, Bernard, et al.
Publicado: (2018)

Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation’s Perspective
por: Yerxa, Benjamin
Publicado: (2018)

Perspectives on: Information coding in mammalian sensory physiology
por: Farley, Robert A., et al.
Publicado: (2011)

A Patient's Perspective on Health Information Management
por: Lytle, James H.
Publicado: (2017)

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug Development
por: Harnisch, L, et al.
Publicado: (2013)

Deciphering next-generation pharmacogenomics: an information technology perspective
por: Potamias, George, et al.
Publicado: (2014)

Immunization Information System and Informatics to Promote Immunizations: Perspective From Minnesota Immunization Information Connection
por: Muscoplat, Miriam Halstead, et al.
Publicado: (2017)

The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives
por: Niazi, Sarfaraz K
Publicado: (2023)

Guest Editorial: Regulatory Acceptance of Toxicogenomics Data
por: Frueh, Felix W., et al.
Publicado: (2004)

Perspectives on How to Drug an Ion Channel
por: Andersen, Olaf Sparre
Publicado: (2008)

A perspective on the current use of the phase distribution model for predicting milk‐to‐plasma drug concentration ratio
por: Zhang, Mian, et al.
Publicado: (2022)

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development
por: Visser, S A G, et al.
Publicado: (2013)

COVID-19, Cities and Urban Informal Workers: India in Comparative Perspective
por: Chen, Martha
Publicado: (2020)

The frontier and perspective for tokamak development
por: Li, Jiangang, et al.
Publicado: (2019)

Perspective: How to Develop Nutrient Profiling Models Intended for Global Use: A Manual
por: Drewnowski, Adam, et al.
Publicado: (2021)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
por: Epstein, Robert S
Publicado: (2021)

Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
por: Lu, Zhengwu
Publicado: (2009)

Redox-informed models of global biogeochemical cycles
por: Zakem, Emily J., et al.
Publicado: (2020)

Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives
por: Pawełczyk, Anna, et al.
Publicado: (2020)

Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities
por: Hayyan, Maan
Publicado: (2023)

Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies?
por: Dauki, Anees M., et al.
Publicado: (2022)

Alternative Perspectives on Impact: The Potential of ALMs and Altmetrics to Inform Funders about Research Impact
por: Dinsmore, Adam, et al.
Publicado: (2014)

A Data-Informed Perspective on Public Preferences for Retaining or Abolishing Biannual Clock Changes
por: Coogan, Andrew N., et al.
Publicado: (2022)

A Perspective on Microneedle-Based Drug Delivery and Diagnostics in Paediatrics
por: Pires, Liliana R, et al.
Publicado: (2019)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness
por: Abdin, Ahmad Yaman, et al.
Publicado: (2023)

Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)

Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers
por: Jayachandran, Priya
Publicado: (2023)

A Model of Advocacy to Inform Action
por: Earnest, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jpp70iri24fve7ab6om8o22cj